Carl Byrnes

Stock Analyst at Northland Capital Markets

(1.30)
# 2,567
Out of 4,460 analysts
14
Total ratings
50%
Success rate
4.58%
Average return

9 Stocks

Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.40
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $2$1.25
Current: $0.71
Upside: +75.81%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $8
Current: $0.50
Upside: +1,508.69%
BrainsWay
Nov 17, 2022
Maintains: Outperform
Price Target: $15$5
Current: $6.23
Upside: -19.74%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60$80
Current: $19.06
Upside: +319.73%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.78
Upside: -
Esperion Therapeutics
May 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $2.29
Upside: -
Aytu BioPharma
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.80
Upside: -
Heron Therapeutics
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $3.29
Upside: -